What is Valkee?
Valkee operates at the intersection of health technology and neuroscience, specializing in the application of bright light to enhance human mental performance and well-being. Leveraging extensive research from Oulu University, Valkee pioneered the world's first bright light headset in 2010. The device has demonstrated clinical efficacy in alleviating symptoms of seasonal affective disorder, with 87% of its user base recommending the product across more than 20 countries. The company's focus on scientifically validated wellness solutions positions it as a key player in the burgeoning digital health market.
How much funding has Valkee raised?
Valkee has raised a total of $9.7M across 1 funding round:
Series A
$9.7M
Series A (2013): $9.7M, investors not publicly disclosed
What's next for Valkee?
The recent strategic investment in Valkee signals a pivotal growth phase, likely aimed at expanding market reach, further clinical research into areas such as cognitive enhancement and jet lag, and scaling production. This capital infusion will empower Valkee to solidify its market leadership and explore new therapeutic applications for its patented bright light technology, potentially driving significant advancements in non-pharmacological mental wellness solutions.
See full Valkee company page
